| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/1389557054867075 |
| P698 | PubMed publication ID | 16178723 |
| P50 | author | Erik De Clercq | Q13578863 |
| P433 | issue | 9 | |
| P304 | page(s) | 805-824 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Mini-Reviews in Medicinal Chemistry | Q3314982 |
| P1476 | title | Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. | |
| P478 | volume | 5 |
| Q36935399 | Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner |
| Q39598216 | An agarose spot chemotaxis assay for chemokine receptor antagonists. |
| Q39304192 | Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9. |
| Q36151685 | Bile salt-dependent lipase interacts with platelet CXCR4 and modulates thrombus formation in mice and humans. |
| Q55513575 | CXCR7 Targeting and Its Major Disease Relevance. |
| Q37406706 | Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents |
| Q37115384 | Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth |
| Q39369977 | Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells |
| Q34098431 | Chemokine expression and control of muscle cell migration during myogenesis |
| Q38776802 | Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer |
| Q39381566 | Crosstalk between Stem and Progenitor Cellular Mediators with Special Emphasis on Vasculogenesis. |
| Q35052404 | Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect |
| Q35777496 | Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application |
| Q28480517 | Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells |
| Q27025151 | Identifying new small molecule anti-invasive compounds for glioma treatment |
| Q36388104 | Inhibition of Porphyromonas gingivalis-induced periodontal bone loss by CXCR4 antagonist treatment. |
| Q33740330 | Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases |
| Q35750964 | Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma |
| Q39025249 | New agents in HSC mobilization. |
| Q36677383 | Novel inhibitors of the early steps of the HIV-1 life cycle |
| Q38803056 | Oncolytic virotherapy for multiple myeloma: past, present, and future |
| Q24652536 | Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function |
| Q35804722 | Plasticity and maintenance of hematopoietic stem cells during development |
| Q28239112 | Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies |
| Q28583772 | Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes |
| Q37144023 | Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers |
| Q39724471 | The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells |
| Q40333177 | The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity |
| Q42411644 | The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis |
| Q35804766 | The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells |
| Q37247686 | The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100. |
| Q36889961 | Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets |
Search more.